Skip to content
Home/GPs/BC Partners
DetailCard
BC Partners

BC Partners

London, United Kingdom·Founded 1986··bcpartners.com

BC Partners is a London-headquartered global alternative investment firm founded in 1986, best known for its large-cap European and North American buyout franchise, with a private equity strategy investing through its flagship BC European Capital and BC Partners fund series. The firm is authorised and regulated in the UK by the Financial Conduct Authority as BC Partners LLP. It also runs credit and real estate strategies alongside the core private equity business.

AUM
€40.0B
Funds
4
vintages 2012–2025
Portfolio
36
Exits
12

BC Partners is a London buyout firm with €40.0B AUM, 36 active companies and 12 exits.

Key takeaways
  • ·10 exits in the last 5 years · consistent DPI cadence.
  • ·Average hold across 12 realized deals: 7 years.
  • ·Fund cadence: ~4Y between vintages · last raise 2025.

Sector breakdown

40 companies
Consumer
6 · 15%
Pharma
5 · 13%
Business Services
4 · 10%
Industrials
4 · 10%
Healthcare
4 · 10%
MedTech
3 · 8%
SaaS
3 · 8%
TMT
3 · 8%

Geography breakdown

11 geographies
Italy
7 · 18%
Germany
7 · 18%
France
6 · 15%
UK
6 · 15%
Netherlands
4 · 10%
US
4 · 10%
Canada
2 · 5%
Switzerland
1 · 3%

Key facts

HQLondon, United Kingdom
Founded1986

Recent exits

Shawbrook

BC Partners took Shawbrook public in 2025 after 8 years.

Forno d'Asolo

BC Partners sold Forno d'Asolo to Investindustrial and Sammontana in 2024 after 6 years.

GardaWorld

BC Partners sold GardaWorld to HPS Investment Partners in 2024 after 5 years.

IMA

BC Partners sold IMA to BDT & MSD Partners in 2024 after 4 years.

Coverage notes

4 funds tracked, 48 portfolio companies (36 active · 12 realized). Verified weekly from public filings and deal announcements.

Funds & portfolio

Every fund BC Partners has raised, with its portfolio companies. Hand-checked from public filings.

4 funds
BC Partners XII
Buyout2025€2.2B4 assets

Unrealized

4 held
CompanyEntry
Biogaran
Pharma · France
2025
Fortidia
Logistics · Italy
2025
IGS GeboJagema
MedTech · Netherlands
2025
InfoRLife
Pharma · Switzerland
2026
BC Partners Fund XI
Buyout2022€6.9B8 assets

Unrealized

8 held
CompanyEntry
CeramTec XI
MedTech · Germany
2022
Davies
Business Services · UK
2021
Edgar Suites
Real Estate · France
2021
Fedrigoni
Industrials · Italy
2022
Havea
Consumer · France
2022
Madison Logic
SaaS · US
2022
PetLab Co.
Consumer · UK
2025
Valtech
IT Services · France
2021
BC European Capital X
Buyout2018€7.0B12 assets7 exits

Unrealized

12 held
CompanyEntry
DentalPro
Healthcare · Italy
2017
Forno d Asolo
Consumer · Italy
2018
GFL Environmental
Industrials · Canada
2018
Keesing
Gaming · Netherlands
2020
Keesing Media Group
Consumer · Netherlands
2021
OneAdvanced
SaaS · UK
2019
PetSmart
Consumer · US
2015
Ponroy Santé (Havea Group)
Healthcare · France
2021
Tentamus
Business Services · Germany
2021
United Group
Telecom · Serbia
2018
VetPartners
Healthcare · UK
2018
Women's Care Enterprises
Healthcare · US
2020

Realized

7 exits
CompanyEntryExitTypeBuyerMOIC
CeramTec
Industrials · Germany
20182022SecondaryBC Partners Fund XI and CPP Investments–
Forno d'Asolo
Consumer · Italy
20182024Trade SaleInvestindustrial and Sammontana–
GardaWorld
Business Services · Canada
20192024SecondaryHPS Investment Partners–
IMA
Industrials · Italy
20202024Trade SaleBDT & MSD Partners–
Presidio
IT Services · US
20152024Trade SaleClayton Dubilier & Rice–
Shawbrook
Fintech · UK
20172025IPO––
Synthon
Pharma · Netherlands
20192024Trade SaleGoldman Sachs Alternatives–
BC European Capital IX
Buyout2012€6.5B4 assets5 exits

Unrealized

4 held
CompanyEntry
CarTrawler
SaaS · Ireland
2014
Cigierre
Hospitality · Italy
2015
Springer SBM
TMT · Germany
2013
Springer Science+Business Media
TMT · Germany
2013

Realized

5 exits
CompanyEntryExitTypeBuyerMOIC
Acuris
Business Services · UK
20142019Trade SaleION Investment Group–
Aenova
Pharma · Germany
20122024Trade SaleKuhne Holding–
Antelliq
MedTech · France
20132019Trade SaleMerck & Co.–
Pharmathen
Pharma · Greece
20152021Trade SalePartners Group–
Springer Nature
TMT · Germany
20132024IPO––

Other portfolio companies

8 more BC Partners investments not tied to a tracked fund.

About BC Partners

BC Partners is an alternative investment platform with capital deployed across 6 active fund vehicles, headquartered in London. The firm deploys capital across European mid and small-cap businesses spanning TMT, industrials, consumer, healthcare, business services and software.

Investment thesis

The platform combines complementary investment strategies, deploying capital across TMT, industrials, consumer, healthcare, business services and software businesses in the United Kingdom and broader European market. Multi-strategy capital deployment enables flexibility across the business lifecycle, with the partnership culture supporting management teams through growth, transmission and selective M&A across multiple fund vintages and asset classes.

Recent activity

Realised exits across the current platform vintages remain limited, with the portfolio in active deployment and value-creation phase. The platform tracks 6 fund vehicles, 58 active portfolio companies and 0 realised exits across the strategy's history.

Frequently asked questions

What investment strategy does BC Partners focus on?
BC Partners focuses on Buyout strategies in the private equity space.
How many portfolio companies does BC Partners have?
BC Partners has 36 active portfolio companies and 12 completed exits and 4 funds tracked on GP Intel.
Where is BC Partners headquartered?
BC Partners is headquartered in London, United Kingdom.
What is BC Partners's assets under management?
BC Partners manages approximately €40.0B in assets under management.
When was BC Partners founded?
BC Partners was founded in 1986.
What sectors does BC Partners invest in?
BC Partners invests across TMT, Healthcare, Consumer, Industrials, Business Services.
What are BC Partners's recent exits?
Recent realized exits by BC Partners include: Forno d'Asolo (2024) to Investindustrial and Sammontana; GardaWorld (2024) to HPS Investment Partners; IMA (2024) to BDT & MSD Partners; Presidio (2024) to Clayton Dubilier & Rice; Synthon (2024) to Goldman Sachs Alternatives; Aenova (2024) to Kuhne Holding; CeramTec (2022) to BC Partners Fund XI and CPP Investments; Pharmathen (2021) to Partners Group.
Look up another firm or company
Last updated October 2026 · Sourced from public filings · Report an issue